Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the production of angiotensin II receptor antagonists for treating hypertension. Its structure supports high binding affinity to biological targets, making it valuable in developing active drug substances. Also employed in research for designing novel compounds with improved metabolic stability due to the presence of trifluoromethyl groups.